Business
Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira," "Inspira Technologies" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that its U.S. Food and Drug Administration-cleared life-support system, the INSPIRA™ ART100, will be showcased at the American Society of Extracorporeal Technology (AmSECT) 63rd International Conference, taking place March 19-23, 2025, at the Loews Coronado Bay Resort in San Diego, California, by their distrib
About this update from Qtrex Quantum Ltd.
[{"type":"text","content":"Leading perfusion professionals to experience Inspira's FDA-cleared cardiopulmonary bypass INSPIRA™ ART100 technology at premier industry event ","length":147,"tagName":"p"},{"type":"text","content":"RA'ANANA, Israel, March 19, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira," "Inspira Technologies" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that its U.S. Food and Drug Administration-cleared life-support system, the INSPIRA™ ART100, will be showcased at the American Society of Extracorporeal Technology (AmSECT) 63rd International Conference, taking place March 19-23, 2025, at the Loews Coronado Bay Resort in San Diego, California, by their distributor Glo-Med Networks Inc ("Glo-Med").","length":636,"tagName":"p"},{"type":"image","alt":"Inspira_Technologies_Logo","displaySize":"","headline":null,"caption":"Inspira_Technologies_Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":117,"url":"https://media.zenfs.com/en/prnewswire.com/d5bff9013032d21692fda6af75e6daf2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JovsJ3khfYQoI0AORfC.eA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwNjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d5bff9013032d21692fda6af75e6daf2","width":400,"height":117}}},{"type":"text","content":"Conference attendees will have the opportunity to explore Inspira's cutting-edge cardiopulmonary bypass technology at Glo-Med's booth. The INSPIRA ART100 system, which received FDA 510(k) clearance in May 2024 for use in cardiopulmonary bypass procedures, represents an advancement in extracorporeal circulation technology.","length":331,"tagName":"p"},{"type":"text","content":""The AmSECT International Conference brings together leading perfusion professionals, providing an ideal platform to showcase our INSPIRA ART100 system," said Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies. "This event offers an excellent opportunity to further expose our innovative technology to the perfusion community. We look forward to connecting with industry experts and demonstrating how our solutions can support medical professionals."","length":482,"tagName":"p"},{"type":"text","content":"Visitors interested in sch...